Immune responses can be generated locally within human melanoma skin metastases

July 31, 2012, American Association for Cancer Research

In many types of cancer, activated immune cells infiltrate the tumor and influence clinical outcome. It is not always clear where these cells are activated, but results reported in Cancer Research, a journal of the American Association for Cancer Research, indicate that in a subset of patients with metastatic melanoma, they can be activated in the tumor microenvironment.

"Our data provide a new concept in melanoma," said Nicolas van Baren, M.D., Ph.D., a clinical and laboratory investigator at the Ludwig Institute for , the de Duve Institute and the Cancer Centre of Cliniques universitaires Saint-Luc in Brussels, Belgium. "Before we began our study, it was thought that immune responses were triggered in specialized structures known as lymph nodes. Lymphocytes, which are an important subset of , became activated in lymph nodes and then migrated via the blood to the tumor."

Results of his study showed an alternative path whereby naive lymphocytes were activated locally in the . "Fundamental knowledge like this is crucial as we seek to understand how tumors escape antitumor immune responses and how we can develop approaches to counter this," he said.

For the majority of immune responses mounted by our bodies, for example in response to invading microbes, the predominant sites of lymphocyte activation are the lymph nodes, spleen and mucosal-associated lymphoid tissues. All these sites are dedicated to supporting the initiation and maintenance of immune responses. However, in some instances of chronic infection, for example with , ectopic lymphoid structures, or lymphoid structures that resemble lymph nodes and develop at aberrant locations, form at the site of the infection and locally support lymphocyte responses directed against the .

Ectopic lymphoid structures have also been observed in some , including breast, lung and colorectal tumors, but not melanoma. In some studies, their presence has been linked to improved prognosis.

Van Baren and colleagues observed ectopic lymphoid structures in seven out of 29 skin metastases from patients with melanoma. In contrast, no primary melanoma samples examined contained complete ectopic lymphoid structures. However, some of them hosted small blood vessels that are associated with these structures.

Further analyses indicated that the ectopic lymphoid structures were functional, as features indicative of activation of the B cell lymphocyte subset were observed.

"It is important to have established that immune responses can be generated locally, at least in skin metastases," said van Baren. "In fact, this last point, that we detected functional lymphoid structures in skin metastases and not in primary tumors, is extremely intriguing. We think that understanding the reasons for this difference will be highly informative in determining how antimelanoma immune responses develop during disease progression."

The sample size was too small to allow the researchers to draw clinically meaningful conclusions. "Nonetheless, it will be important to look at this moving forward, as it is not yet clear whether these structures are good for the patient and bad for the tumor or good for the tumor and bad for the patient. At this point, there is no indication either way, and we could provide a speculative argument for either."

Explore further: Using Viagra to combat malignant melanoma

Related Stories

Using Viagra to combat malignant melanoma

November 8, 2011
Many tumors cause chronic inflammations, which, in their turn, suppress specific attacks against the tumor by the immune system. Scientists at the German Cancer Research Center and Medical Faculty Mannheim at Heidelberg University ...

Researchers find success with new immune approach to fighting some cancers

June 13, 2012
A national research collaboration of senior researchers, including a researcher from Moffitt Cancer Center, has found that 20 to 25 percent of "heavily pre-treated" patients with a variety of cancers who enrolled in a clinical ...

Researchers creating "designer lymph nodes"

April 29, 2012
Researchers at Moffitt Cancer Center are in the first phase of creating "designer lymph nodes." Designer lymph nodes are built with specialized gene-modified cells that are injected into patients and produce a pre-planned ...

Dendritic cells control lymphocyte entry into lymph nodes

November 17, 2011
Dendritic cells, discovered in 1973 by Ralph Steinman (2011 Nobel prize in Physiology or Medicine) and known for their role as sentinels of the immune system, have an essential function in the development of high endothelial ...

Recommended for you

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.